Avid Bioservices, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CDMO research report →
Companywww.avidbio.com
Avid Bioservices, Inc. , a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant proteins; and offers services, including CGMP clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing, and regulatory submission and support.
- CEO
- Nicholas Stewart Green MBA
- IPO
- 1994
- Employees
- 371
- HQ
- Tustin, CA, US
Price Chart
Valuation
- Market Cap
- $798.90M
- P/E
- -5.61
- P/S
- 5.71
- P/B
- 12.96
- EV/EBITDA
- -84.37
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 5.23%
- Op Margin
- -13.35%
- Net Margin
- -100.60%
- ROE
- -112.44%
- ROIC
- -6.95%
Growth & Income
- Revenue
- $139.91M · -6.27%
- Net Income
- $-140,753,000 · -25234.46%
- EPS
- $-2.23 · -24877.78%
- Op Income
- $-18,678,000
- FCF YoY
- 76.96%
Performance & Tape
- 52W High
- $12.51
- 52W Low
- $5.90
- 50D MA
- $12.36
- 200D MA
- $10.25
- Beta
- 1.41
- Avg Volume
- 1.58M
Get TickerSpark's AI analysis on CDMO
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Feb 5, 25 | Ziebell Mark R | sell | 14,286 |
| Feb 5, 25 | Ziebell Mark R | sell | 21,429 |
| Feb 5, 25 | Ziebell Mark R | sell | 1,733 |
| Feb 5, 25 | Ziebell Mark R | sell | 98,120 |
| Feb 5, 25 | Ziebell Mark R | sell | 17,679 |
| Feb 5, 25 | Ziebell Mark R | sell | 51,413 |
| Feb 5, 25 | Ziebell Mark R | sell | 55,310 |
| Feb 5, 25 | Ziebell Mark R | sell | 108,579 |
| Feb 5, 25 | Ziebell Mark R | sell | 66,799 |
| Feb 5, 25 | Thoma Jeanne | sell | 45,611 |
Our CDMO Coverage
We haven't published any research on CDMO yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate CDMO Report →